按诊断领域、模式、平台、最终用户、地区划分的全球即时检测 (POCT) 市场：COVID-19 的影响、最新发展、公司概况 - 未来预测（至 2028 年）

到 2028 年，全球即时检测 (POCT) 市场预计将达到约 650 亿美元。在过去 20 年中，随着医院内外对准确和快速检测的需求不断增加，床旁 (POC) 检测呈指数级增长。 POCT 或床边测试是一种医学诊断测试，使医生和医务人员能够在几分钟内获得正确、实时、实验室质量的诊断结果。

近年来，便携式检测设备的引入取得了进展，POC检测已从医院转移到工作场所、家庭、灾难，最近又转移到便利店等各种医疗环境。此外，印度和中国等新兴国家的传染病、心血管疾病和糖尿病等慢性病发病率不断上升，推动了对 POC 检测服务的需求。因此，越来越多的传染病和慢性病将在不久的将来加强即时检测市场。

POCT 市场：按诊断细分市场预测

基于诊断细分市场，市场以血糖检测细分市场为主。经济体和发达国家糖尿病患病率的增加以及患者对家庭检测的倾向增加是在预测期内推动该细分市场增长的主要驱动力。此外，传染病部门在 2021 年占第二大收入份额。另一方面，预计心臟标誌物部分将在预测期内出现显着增长。

POCT 市场：按模式预测

按模式，市场以基于 POTC 的测试部分为主。由于其成本效益和易于操作，该细分市场在 2021 年将主导整个 POCT 市场。高细分增长率归因于OTC测试数量的增加，例如血糖测试和妊娠测试，它们可以在几秒钟内提供结果。

POCT 市场：按平台预测

按平台划分，横向流动分析 (LFA) 部分将在 2021 年占据最大的收入份额。基于侧向流动分析的 POC 测试越来越多地被采用作为冗长的传统实验室流程的替代方案。此外，免疫分析技术 POCT 市场预计将在预测期内出现显着增长。

POCT 市场：最终用户预测

POCT 市场以医院为主，其次是诊所。随着需要适当监测的慢性疾病（例如癌症和心血管疾病）的日益流行，医院和诊所需要微创手术。由于家庭和远程监控的偏好日益增加以及家庭护理用户对快速测试的需求不断增加，预计家庭医疗保健部门在预测期内将呈现最高增长率。

POCT 市场：区域预测

按地区划分，POCT 市场以北美为主，预计在预测期内将保持其地位。这是由于需要便携式和快速诊断的慢性病和传染病的流行率上升、产品批准的增加以及政府加大力度支持该地区采用 POCT。欧洲在 POCT 市场中占有第二高的份额。由于老年人口的增加、目标疾病的患病率上升、家庭护理需求的增加以及先进技术的新产品的推出，亚太地区的 POCT 市场将在预测期内以最快的速度增长。预计

内容

第 1 章执行摘要

第 2 章 COVID-19 对全球即时检测市场的影响

第 3 章全球即时检测市场和预测（2010-2028 年）

第 4 章全球即时检测市场份额和预测（2010-2028）

第 5 章全球即时检测市场和预测：按诊断细分市场（2010-2028 年）

• 血糖检测
• 心臟标誌物测试
• 血脂/胆固醇测试
• 凝血试验
• 传染病测试
• 尿液分析
• 药物滥用测试
• 粪便潜血试验
• 妊娠和不孕检查
• 肿瘤标誌物检测
• 紧急救生检查
• HbA1c 测试
• 临床化学
• 胆红素测试
• 验血

第 6 章全球即时检测市场和预测：按模式（2010-2028 年）

• 基于处方的测试
• 基于 OTC 的检验

第 7 章全球即时检测市场和预测：按平台（2015-2028 年）

• 横向流动检测
• 免疫测定
• 微流体
• 油尺
• 分子诊断
• 其他平台

第 8 章全球即时检测市场和预测：按最终用户分类（2010-2028 年）

• 医院
• 医务室
• 检查室
• 带护理的住房
• 居家护理

第 9 章全球即时检测市场和预测：按地区划分（2010-2028 年）

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

第 10 章全球即时检测市场：最新发展

第 11 章即时检测市场：公司简介

• 雅培实验室
  • 公司概况
  • 产品组合
  • 财务分析
  • 业务战略
• Siemens Healthineers
• Roche Diagnostics
• Quest Diagnostics
• Becton, Dickinson and Company
• ACON Laboratories
• Abaxis, Inc.
• Abingdon Health, Ltd.
• Access Bio, Inc.
• AccuBioTech Co, Ltd.
• Akers Biosciences, Inc.
• Alfa Scientific Designs, Inc
• American Bio Medica Corporation
• AmniSure International
• Aquila Diagnostic Systems, Inc
• ARKRAY Inc
• Artron Laboratories Inc.
• Ascensia Diabetes Care Holdings AG
• Immune IQ (Formerly Ativa)
• Atlas Link Biotech Co., Ltd
• Audit Diagnostics
• Augurix Diagnostics
• Autobio Diagnostics Co., Ltd
• Axxin
• Beckman Coulter, Inc
• Bhat Bio-Tech India Private Ltd. (BBI)
• bioLytical Laboratories
• BioMedomics, Inc
• Biomerica, Inc.
• bioMerieux SA
• Biophor Diagnostics, Inc
• Biosensia Ltd.
• Bio-Rad Laboratories Inc.
• Bioscan Screening Systems, Inc.
• BTNX Inc.
• Boditech Med Inc
• Xiamen Boson Biotech Co. Ltd
• Calypte Biomedical Corporation
• Cepheid, Inc
• Chembio Diagnostic Systems, Inc.
• Clarity Diagnostics, LLC
• Confirm Biosciences
• CTK Biotech, Inc.
• Daktari Diagnostics
• Danaher Corporation
• Dexcom, Inc
• DIALAB GmbH
• DiaSys Diagnostic Systems GmbH
• Diazyme Laboratories, Inc.
• DNA Electronics Ltd. (DNAe)
• EKF Diagnostics Holdings plc
• ELITechGroup, Inc.
• Eurolyser Diagnostica GmbH
• Exact Sciences Corporation
• Exalenz Bioscience Ltd.
• Genedrive plc
• GeTein BioMedical, Inc.
• Helena Laboratories
• Hemosure, Inc.
• Immunostics, Inc.
• Instrumentation Laboratory
• JAL Innovation PTE LTD
• Jant Pharmacal Corporation
• LamdaGen Corporation
• LifeScan, Inc
• LifeSign, LLC
• MBio Diagnostics, Inc (Now LightDeck Diagnostics)
• Medix Biochemica
• Medtronic, Inc.
• A. Menarini Diagnostics S.R.L.
• Meridian Bioscience, Inc
• Nano-Ditech Corporation
• Noble Medical, Inc
• Nova Biomedical, Corp.
• Oasis Diagnostics Corporation
• OPKO Health, Inc
• OPTI Medical Systems, Inc
• OraSure Technologies, Inc
• Polymed Therapeutics Inc.
• Preventis GmbH
• Princeton Biomeditech Corporation
• QuantuMDx Group Limited
• Radiometer Medical A/S
• Response Biomedical Corp
• Reszon Diagnostics International Sdn. Bhd.
• Samsung Healthcare
• Savyon Diagnostics
• Sekisui Diagnostics LLC
• Siloam Biosciences, Inc
• Sysmex Corporation
• TECHLAB, Inc.
• Teco Diagnostics
• Trinity Biotech PLC
• Trividia Health
• Tulip Diagnostics Ltd
• Veredus Laboratories PTE Ltd
• Vircell
• WAMA Diagnostica
• Wave 80 Biosciences
• Werfen
• Quidel Corporation
• Thermo Fisher Scientific
• Mesa Biotech Inc.
• GeneSTAT Molecular Diagnostics, LLC
• Biocartis Group NV
• Johnson and Johnson Service, Inc.

第 12 章全球即时检测市场：驱动因素

• 床旁检测：迈向未来的一步
• 慢性病和传染病的高发率
• 继续手动扩展 PoC（包括自检）
  • 即时检测的承诺
  • 即时检测的可能性：“令人担忧”
  • 中心和辐条
  • 教育
• POCT技术进步拉动市场需求

第 13 章全球即时检测市场：挑战

• 在低收入和中等收入国家进行即时 (POC) 检测的障碍
  • 广泛采用 PoC 技术的障碍
  • 床旁检测存在技术、管理和运营方面的障碍
  • 与卫生系统相关的即时检测障碍
  • 即时检测的经济障碍
• 政策/监管指南和资金挑战
• PoC 诊断开发中的基础设施障碍和挑战

The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.

Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per statistics of the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes globally, and it is estimated to reach 643 million by 2030 and 783 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.

Impact of COVID-19 on Global Point of Care Testing Market

The COVID-19 outbreak has become a global stress test. The disease has infected around 596.2 million people worldwide. Globally the death toll has reached 6,456,879 according to the latest statistics from the Worldometers (as of August 16, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak stirred an unprecedented public health concern across the globe and has positively impacted the point of care testing market growth.

The need for speedy diagnostic results has made point-of-care testing a vital diagnostic tool. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. The usage of POC kits in COVID-19 diagnosis has increased at a significant pace owing to multiple advantages such as smaller size, portability, convenience, and precise outcomes, among others. These tests are capable of operating in any low-resource setting including home care settings and are needed to adequately combat the COVID-19 pandemic.

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe.

The infectious diseases segment held second largest revenue share in 2021. Infectious diseases are the primary cause of mortality globally, and according to figures from the Clinical Microbiology and Infection journal, they claim over 14 million lives annually, making up around 25% of the 56 million deaths recorded worldwide. Infectious disease testing has shifted from centralized to decentralized POC testing, resulting in better patient care. The market is being driven by increased demand for quick tests, which has prompted industry players to deliver POC solutions to decentralized regions. For instance, Abbott has introduced ID NOW, the world's quickest molecular POC test, which provides COVID-19 findings in 13 minutes and is usable in a variety of decentralized healthcare settings.

Cardiac marker segment is expected to grow at a significant rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers.

By Mode - Global Point of Care Testing Market & Forecast

On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. The segment is dominating the overall POCT market in 2021 as these tests are cost-effective as well as easy operative in nature. High segmental growth is attributed to rising number of OTC testing such as blood glucose tests and pregnancy tests that provides result in few seconds. These tests do not require skilled professional to perform and can be self-tested by individuals, thereby boosting the market growth. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.

By Platform - Global Point of Care Testing Market & Forecast

By platform, the Lateral Flow Assays (LFA) segment accounted for largest revenue share in 2021. POC tests based on lateral flow assays are increasingly being employed to replace long, conventional laboratory processes. Lateral flow assays are simple devices used to detect the presence or absence of target analytes in samples. These assays help in detecting and quantifying analytes in complex mixtures and provide results within 30 minutes after the sample is placed on the device. The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe. Rapid immunoassays improve quality of care through its performance at point of care facilities, such as student health clinics, labor and delivery suites and emergency rooms. The cost-effectiveness offered by these immunoassays will influence segment growth during the forecast period.

By End Users - Global Point of Care Testing Market & Forecast

Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

By Region - Global Point of Care Testing Market & Forecast

The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.

iGATE RESEARCH report titled "Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028" provides a comprehensive analysis of the Global Point of Care Testing Market.

This 270 Page report with 78 Figures and 12 Tables has been analyzed from 11 View Points:

1) Global - Point of Care Testing Market & Forecast (2010 - 2028)

2) Impact of COVID-19 on Global Point of Care Testing Market

3) Global - Point of Care Testing Market Share and Forecast (2010 - 2028)

4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)

5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)

6) By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)

7) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)

8) By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)

9) Global Point of Care Testing Market - Recent Developments

10) Global Point of Care Testing Market - 106 Company Profiles

11) Global Point of Care Testing Market - Growth Drivers & Challenges

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

1. Blood Glucose Testing

2. Cardiac Marker Testing

3. Lipid Panel/Cholesterol Testing

4. Coagulation Testing

5. Infectious Disease Testing

6. Urinalysis Testing

7. Drug of Abuse Testing

8. Fecal Occult Blood Testing

9. Pregnancy & Fertility Testing

10. Tumor Marker Testing

11. Critical Care Testing

12. HbA1c Testing

13. Clinical Chemistry Testing

14. Bilirubin Testing

15. Hematology Testing

By Mode - Global Point of Care Testing Market & Forecast

• Prescription-based Testing
• OTC-based Testing

By Platform - Global Point of Care Testing Market & Forecast

• Lateral Flow Assays
• Immunoassays
• Microfluidics
• Dipsticks
• Molecular Diagnostics
• Others

By End Users - Global Point of Care Testing Market & Forecast

1. Hospitals

2. Clinics

3. Laboratories

4. Assisted Living Healthcare Facilities

5. Home Care

By Region - Global Point of Care Testing Market & Forecast

1. North America

2. Europe

3. Asia Pacific

4. Latin America

5. Middle East & Africa

Global Point of Care Testing Market - 106 Company Profiles

1. Abbott Laboratories 2. Siemens Healthineers 3. Roche Diagnostics 4. Quest Diagnostics 5. Becton, Dickinson and Company 6. ACON Laboratories 7. Abaxis, Inc 8. Abingdon Health, Ltd 9. Access Bio, Inc. 10. AccuBioTech Co, Ltd. 11. Akers Biosciences, Inc. 12. Alfa Scientific Designs, Inc 13. American Bio Medica Corporation 14. AmniSure International 15. Aquila Diagnostic Systems, Inc 16. ARKRAY Inc 17. Artron Laboratories Inc. 18. Ascensia Diabetes Care Holdings AG 19. Immune IQ (Formerly Ativa) 20. Atlas Link Biotech Co., Ltd 21. Audit Diagnostics 22. Augurix Diagnostics 23. Autobio Diagnostics Co., Ltd 24. Axxin 25. Beckman Coulter, Inc 26. Bhat Bio-Tech India Private Ltd. 27. bioLytical Laboratories 28. BioMedomics, Inc 29. Biomerica, Inc. 30. bioMerieux SA 31. Biophor Diagnostics, Inc 32. Bio-Rad Laboratories Inc. 33. Bioscan Screening Systems, Inc. 34. Biosensia Ltd. 35. BTNX Inc. 36. Boditech Med Inc 37. Xiamen Boson Biotech Co. Ltd 38. Calypte Biomedical Corporation 39. Cepheid, Inc 40. Chembio Diagnostic Systems, Inc 41. Clarity Diagnostics, LLC 42. Confirm Biosciences 43. CTK Biotech, Inc. 44. Daktari Diagnostics 45. Danaher Corporation 46. Dexcom, Inc 47. DIALAB GmbH 48. DiaSys Diagnostic Systems GmbH 49. Diazyme Laboratories, Inc. 50. DNA Electronics Ltd. (DNAe) 51. EKF Diagnostics Holdings plc 52. ELITechGroup, Inc. 53. Eurolyser Diagnostica GmbH 54. Exact Sciences Corporation 55. Exalenz Bioscience Ltd 56. Genedrive plc 57. GeTein BioMedical, Inc. 58. Helena Laboratories 59. Hemosure, Inc. 60. Immunostics, Inc. 61. Instrumentation Laboratory 62. JAL Innovation PTE LTD 63. Jant Pharmacal Corporation 64. LamdaGen Corporation 65. LifeScan, Inc 66. LifeSign, LLC 67. MBio Diagnostics, Inc (Now LightDeck Diagnostics) 68. Medix Biochemica 69. Medtronic, Inc 70. A. Menarini Diagnostics S.R.L. 71. Meridian Bioscience, Inc 72. Nano-Ditech Corporation 73. Noble Medical, Inc 74. Nova Biomedical, Corp. 75. Oasis Diagnostics Corporation 76. OPKO Health, Inc 77. OPTI Medical Systems, Inc 78. OraSure Technologies, Inc 79. Polymed Therapeutics Inc. 80. Preventis GmbH 81. Princeton Biomeditech Corporation 82. QuantuMDx Group Limited 83. Radiometer Medical A/S 84. Response Biomedical Corp 85. Reszon Diagnostics International Sdn. Bhd. 86. Samsung Healthcare 87. Savyon Diagnostics 88. Sekisui Diagnostics LLC 89. Siloam Biosciences, Inc 90. Sysmex Corporation 91. TECHLAB, Inc. 92. Teco Diagnostics 93. Trinity Biotech PLC 94. Trividia Health 95. Tulip Diagnostics Ltd 96. Veredus Laboratories PTE Ltd 97. Vircell 98. WAMA Diagnostica 99. Wave 80 Biosciences 100. Werfen 101. Quidel Corporation 102. Thermo Fisher Scientific 103. Mesa Biotech Inc 104. GeneSTAT Molecular Diagnostics, LLC 105. Biocartis Group NV 106. Johnson and Johnson Service, Inc.

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Point of Care Testing Market

3. Global - Point of Care Testing Market & Forecast (2010 - 2028)

4. Global - Point of Care Testing Market Share & Forecast (2010 - 2028)

• 4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
• 4.2 By Mode - Global Point of Care Testing Market Share & Forecast
• 4.3 By Platform - Global Point of Care Testing Market Share & Forecast (2015 - 2028)
• 4.4 By End Users - Global Point of Care Testing Market Share & Forecast
• 4.5 By Region - Point of Care Testing Market Share & Forecast

5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)

• 5.1 Blood Glucose Testing Market & Forecast
• 5.2 Cardiac Marker Testing Market & Forecast
• 5.3 Lipid Panel/Cholesterol Testing Market & Forecast
• 5.4 Coagulation Testing Market & Forecast
• 5.5 Infectious Disease Testing Market & Forecast
• 5.6 Urinalysis Testing Market & Forecast
• 5.7 Drug of Abuse Testing Market & Forecast
• 5.8 Fecal Occult Blood Testing Market & Forecast
• 5.9 Pregnancy & Fertility Testing Market & Forecast
• 5.10 Tumor Marker Testing Market & Forecast
• 5.11 Critical Care Testing Market & Forecast
• 5.12 HbA1c Testing Market & Forecast
• 5.13 Clinical Chemistry Testing Market & Forecast
• 5.14 Bilirubin Testing Market & Forecast
• 5.15 Hematology Testing Market & Forecast

6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)

• 6.1 Prescription-based Testing Market & Forecast
• 6.2 OTC-based Testing Market & Forecast

7. By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)

• 7.1 Global - Point of Care Diagnostics Market for Lateral Flow Assays
• 7.2 Global - Point of Care Diagnostics Market for Immunoassays
• 7.3 Global - Point of Care Diagnostics Market for Microfluidics
• 7.4 Global - Point of Care Diagnostics Market for Dipsticks
• 7.5 Global - Point of Care Diagnostics Market for Molecular Diagnostics
• 7.6 Global - Point of Care Diagnostics Market for Other Platforms

8. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)

• 8.1 Hospitals - Point of Care Testing Market & Forecast
• 8.2 Clinics - Point of Care Testing Market & Forecast
• 8.3 Laboratories - Point of Care Testing Market & Forecast
• 8.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
• 8.5 Home Care - Point of Care Testing Market & Forecast

9. By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)

• 9.1 North America - Point of Care Testing Market & Forecast
• 9.2 Europe - Point of Care Testing Market & Forecast
• 9.3 Asia Pacific - Point of Care Testing Market & Forecast
• 9.4 Latin America - Point of Care Testing Market & Forecast
• 9.5 Middle East and Africa - Point of Care Testing Market & Forecast

10. Global Point of Care Testing Market - Recent Developments

11. Point of Care Testing Market - Company Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Company Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Financial Insight
  • 11.1.4 Business Strategy
• 11.2 Siemens Healthineers
  • 11.2.1 Company Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Financial Insight
  • 11.2.4 Business Strategy
• 11.3 Roche Diagnostics
  • 11.3.1 Company Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Financial Insight
  • 11.3.4 Business Strategy
• 11.4 Quest Diagnostics
  • 11.4.1 Company Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Financial Insight
  • 11.4.4 Business Strategy
• 11.5 Becton, Dickinson and Company
  • 11.5.1 Company Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Financial Insight
  • 11.5.4 Business Strategy
• 11.6 ACON Laboratories
  • 11.6.1 Company Overview
  • 11.6.2 Product Portfolio
• 11.7 Abaxis, Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Product Portfolio
• 11.8 Abingdon Health, Ltd.
  • 11.8.1 Company Overview
  • 11.8.2 Product Portfolio
• 11.9 Access Bio, Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Product Portfolio
• 11.10 AccuBioTech Co, Ltd.
• 11.11 Akers Biosciences, Inc.
• 11.12 Alfa Scientific Designs, Inc
• 11.13 American Bio Medica Corporation
• 11.14 AmniSure International
• 11.15 Aquila Diagnostic Systems, Inc
• 11.16 ARKRAY Inc
• 11.17 Artron Laboratories Inc.
• 11.18 Ascensia Diabetes Care Holdings AG
• 11.19 Immune IQ (Formerly Ativa)
• 11.20 Atlas Link Biotech Co., Ltd
• 11.21 Audit Diagnostics
• 11.22 Augurix Diagnostics
• 11.23 Autobio Diagnostics Co., Ltd
• 11.24 Axxin
• 11.25 Beckman Coulter, Inc
• 11.26 Bhat Bio-Tech India Private Ltd. (BBI)
• 11.27 bioLytical Laboratories
• 11.28 BioMedomics, Inc
• 11.29 Biomerica, Inc.
• 11.30 bioMerieux SA
• 11.31 Biophor Diagnostics, Inc
• 11.32 Biosensia Ltd.
• 11.33 Bio-Rad Laboratories Inc.
• 11.34 Bioscan Screening Systems, Inc.
• 11.35 BTNX Inc.
• 11.36 Boditech Med Inc
• 11.37 Xiamen Boson Biotech Co. Ltd
• 11.38 Calypte Biomedical Corporation
• 11.39 Cepheid, Inc
• 11.40 Chembio Diagnostic Systems, Inc.
• 11.41 Clarity Diagnostics, LLC
• 11.42 Confirm Biosciences
• 11.43 CTK Biotech, Inc.
• 11.44 Daktari Diagnostics
• 11.45 Danaher Corporation
• 11.46 Dexcom, Inc
• 11.47 DIALAB GmbH
• 11.48 DiaSys Diagnostic Systems GmbH
• 11.49 Diazyme Laboratories, Inc.
• 11.50 DNA Electronics Ltd. (DNAe)
• 11.51 EKF Diagnostics Holdings plc
• 11.52 ELITechGroup, Inc.
• 11.53 Eurolyser Diagnostica GmbH
• 11.54 Exact Sciences Corporation
• 11.55 Exalenz Bioscience Ltd.
• 11.56 Genedrive plc
• 11.57 GeTein BioMedical, Inc.
• 11.58 Helena Laboratories
• 11.59 Hemosure, Inc.
• 11.60 Immunostics, Inc.
• 11.61 Instrumentation Laboratory
• 11.62 JAL Innovation PTE LTD
• 11.63 Jant Pharmacal Corporation
• 11.64 LamdaGen Corporation
• 11.65 LifeScan, Inc
• 11.66 LifeSign, LLC
• 11.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
• 11.68 Medix Biochemica
• 11.69 Medtronic, Inc.
• 11.70 A. Menarini Diagnostics S.R.L.
• 11.71 Meridian Bioscience, Inc
• 11.72 Nano-Ditech Corporation
• 11.73 Noble Medical, Inc
• 11.74 Nova Biomedical, Corp.
• 11.75 Oasis Diagnostics Corporation
• 11.76 OPKO Health, Inc
• 11.77 OPTI Medical Systems, Inc
• 11.78 OraSure Technologies, Inc
• 11.79 Polymed Therapeutics Inc.
• 11.80 Preventis GmbH
• 11.81 Princeton Biomeditech Corporation
• 11.82 QuantuMDx Group Limited
• 11.83 Radiometer Medical A/S
• 11.84 Response Biomedical Corp
• 11.85 Reszon Diagnostics International Sdn. Bhd.
• 11.86 Samsung Healthcare
• 11.87 Savyon Diagnostics
• 11.88 Sekisui Diagnostics LLC
• 11.89 Siloam Biosciences, Inc
• 11.90 Sysmex Corporation
• 11.91 TECHLAB, Inc.
• 11.92 Teco Diagnostics
• 11.93 Trinity Biotech PLC
• 11.94 Trividia Health
• 11.95 Tulip Diagnostics Ltd
• 11.96 Veredus Laboratories PTE Ltd
• 11.97 Vircell
• 11.98 WAMA Diagnostica
• 11.99 Wave 80 Biosciences
• 11.100 Werfen
• 11.101 Quidel Corporation
• 11.102 Thermo Fisher Scientific
• 11.103 Mesa Biotech Inc.
• 11.104 GeneSTAT Molecular Diagnostics, LLC
• 11.105 Biocartis Group NV
• 11.106 Johnson and Johnson Service, Inc.

12. Global Point of Care Testing Market - Growth Drivers

• 12.1 Point-of-care Testing: A Step to the Future
• 12.2 High Prevalence of Chronic and Infectious Diseases
• 12.3 Continued Expansion of Point of Care Including Self Testing
  • 12.3.1 The Promise of Point-of-Care Testing
  • 12.3.2 Future of Point of Care Testing - The 'Worried Well'
  • 12.3.3 Hub and Spoke
  • 12.3.4 Education
• 12.4 Technological Advancement in POCT to Spur Market Demand

13. Global Point of Care Testing Market - Challenges

• 13.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
  • 13.1.1 Barriers to Adoption & Scale-up of POC Technologies
  • 13.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
  • 13.1.3 Health System Related Barriers of Point of Care Tests
  • 13.1.4 Economic Barriers of Point of Care Tests
• 13.2 Policy/Regulatory Guidelines and Funding Challenges
• 13.3 Infrastructure Barriers and Challenges with POC Diagnostics Development

List of Figures

List of Figures:

• Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2021
• Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2022 - 2028
• Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2021
• Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2022 - 2028
• Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2021
• Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2022 - 2028
• Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2021
• Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2022 - 2028
• Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2021
• Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2022 - 2028
• Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2021
• Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2022 - 2028
• Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2021
• Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2022 - 2028
• Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2021
• Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2022 - 2028
• Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2021
• Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2022 - 2028
• Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2021
• Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2022 - 2028
• Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2021
• Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2022 - 2028
• Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2021
• Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2022 - 2028
• Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2021
• Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2022 - 2028
• Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2021
• Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2022 - 2028
• Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2021
• Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2022 - 2028
• Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2021
• Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2022 - 2028
• Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2021
• Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2022 - 2028
• Figure 7-1: Global POCT - Lateral Flow Assays Market (Million US$), 2015 - 2021
• Figure 7-2: Global POCT - Forecast for Lateral Flow Assays Market (Million US$), 2022 - 2028
• Figure 7-3: Global POCT - Immunoassays Market (Million US$), 2015 - 2021
• Figure 7-4: Global POCT - Forecast for Immunoassays Market (Million US$), 2022 - 2028
• Figure 7-5: Global POCT - Microfluidics Market (Million US$), 2015 - 2021
• Figure 7-6: Global POCT - Forecast for Microfluidics Market (Million US$), 2022 - 2028
• Figure 7-7: Global POCT - Dipsticks Market (Million US$), 2015 - 2021
• Figure 7-8: Global POCT - Forecast for Dipsticks Market (Million US$), 2022 - 2028
• Figure 7-9: Global POCT - Molecular Diagnostics Market (Million US$), 2015 - 2021
• Figure 7-10: Global POCT - Forecast for Molecular Diagnostics Market (Million US$), 2022 - 2028
• Figure 7-11: Global POCT - Other Platforms Market (Million US$), 2015 - 2021
• Figure 7-12: Global POCT - Forecast for Other Platforms Market (Million US$), 2022 - 2028
• Figure 8-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 8-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 8-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 8-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 8-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 8-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 8-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 8-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 8-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 8-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 9-1: North America - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 9-2: North America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 9-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 9-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 9-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 9-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 9-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 9-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 9-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2021
• Figure 9-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
• Figure 11-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2021
• Figure 11-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
• Figure 11-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2021
• Figure 11-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
• Figure 11-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2021
• Figure 11-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2022 - 2028
• Figure 11-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2021
• Figure 11-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2022 - 2028
• Figure 11-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2021
• Figure 11-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028

List of Tables:

• Table 4-1: By Diagnostics Segment - Global Point of Care Testing Market Share (Percent), 2010 - 2021
• Table 4-2: By Diagnostics Segment - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
• Table 4-3: By Mode - Global Point of Care Testing Market Share (Percent), 2010 - 2021
• Table 4-4: By Mode - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
• Table 4-5: By Platform - Global Point of Care Testing Market Share (Percent), 2015 - 2021
• Table 4-6: By Platform - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
• Table 4-7: By End Users - Global Point of Care Testing Market Share (Percent), 2010 - 2021
• Table 4-8: By End Users - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
• Table 4-9: By Region - Point of Care Testing Market Share (Percent), 2010 - 2021
• Table 4-10: By Region - Forecast for Point of Care Testing Market Share (Percent), 2022 - 2028
• Table 11-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio
• Table 13-1: POCT - Barriers to Adoption and Scale-up of POC Technologies